Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Marks and Clerk
Marks and Clerk
Activities:
Finance
Patient Experience
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
The (r)evolution of biocatalysis in API synthesis
Explore Farmhispania Group’s enzyme toolbox to develop cost-effective, green-by-design synthetic routes for the cGMP production of your small-molecule NCEs
From batch to continuous chemistry to continuous processing
The main challenge in many flow reactors lies in achieving a smooth and continuous flow within microchannels. Dec Group focuses on effectively transporting solid materials and...
PCI Pharma Services commences installation of sterile fill-finish and lyophilisation line
The Bedford, NH site will advance PCI's manufacturing capabilities with twin lyophilisers and a large-scale isolator filling line, making this the third sterile fill-finish...
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Ingredients
Taking a multifaceted approach to combatting superbugs
Paul Chapman, Partner at Marks & Clerk LLP, takes a look at research underway for testing a compound on Gram-negative bacteria known for being the most difficult to treat of all infections
Research & Development
UK pharmaceutical patents up 20%
Innovation seen to be key as this sector continues to grow and export its technology to the wider world, reports Marks & Clerk
Finance
UK pharma and biotech patent filings surge, investor confidence sign?
The European Patent Office has reported a surge in pharmaceutical and biotechnology patents – potentially a sign of growing investor confidence in these sectors, according to IP firm Marks & Clerk
Patient Experience
Rare disease patent filings on the rise, finds report, but antibiotics may lose another decade
Research into new antibiotic classes represents less than 5% of antibiotics-related patent filings
Patient Experience
US changes its patent laws
America Invents Act replaces first-to-invent system with first-to-file system
Regulatory
Parliament approves EU unitary patent rules
Patent package includes the unitary patent, language regime and unified patent court
Regulatory
EU moves a step closer to establishing a unitary patent
EU patent protection expected to become less expensive, simpler and more efficient
Subscribe now